To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a ...

The UChicago Medicine team will be led by Odunsi as co-principal investigator and includes Christopher Weber, Savas Tay, and ...

Cancer has a high death rate with delayed diagnosis of the disease being one of the main reasons for its fatality. Early ...

Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of ...

Researchers have created a groundbreaking antibody that combines targeting, delivery, and immune activation to treat cancer, ...

Innovative urinary miRNA profiling shows potential for early pancreatic cancer detection, with high accuracy and sensitivity, ...

A new risk score model for hepatocellular carcinoma using standard clinical data can better identify individuals at risk ...

A new collaboration between Home Base, Mass General, and John Hancock aims to enhance cancer detection in veterans, a group ...

Today, John Hancock, a unit of Toronto-based Manulife, announced it is providing free access to Galleri®, GRAIL's multi-cancer early detection (MCED) test, to special operations veterans receiving ...

Grail Inc ( (GRAL) ) has released its Q3 earnings. Here is a breakdown of the information Grail Inc presented to its investors. Grail Inc. is a ...

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...